"Mice, Nude" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D008819
						 | 			
					
					
						| MeSH Number(s) | 
						
							 B01.050.150.900.649.313.992.635.505.500.550.500 
						 | 
					
					
						| Concept/Terms | 
						
							Mice, Nude- Mice, Nude
 - Athymic Mice
 - Mouse, Nude
 - Nude Mouse
 - Nude Mice
 - Mouse, Athymic
 - Athymic Mouse
 - Mice, Athymic
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Mice, Nude".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Mice, Nude".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Mice, Nude" by people in this website by year, and whether "Mice, Nude" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 0 | 7 | 7 | 
| 1996 | 0 | 7 | 7 | 
| 1997 | 0 | 5 | 5 | 
| 1998 | 0 | 9 | 9 | 
| 1999 | 0 | 13 | 13 | 
| 2000 | 0 | 10 | 10 | 
| 2001 | 1 | 13 | 14 | 
| 2002 | 0 | 21 | 21 | 
| 2003 | 0 | 16 | 16 | 
| 2004 | 0 | 21 | 21 | 
| 2005 | 0 | 18 | 18 | 
| 2006 | 0 | 14 | 14 | 
| 2007 | 0 | 18 | 18 | 
| 2008 | 0 | 16 | 16 | 
| 2009 | 0 | 25 | 25 | 
| 2010 | 0 | 16 | 16 | 
| 2011 | 0 | 23 | 23 | 
| 2012 | 0 | 26 | 26 | 
| 2013 | 0 | 19 | 19 | 
| 2014 | 0 | 31 | 31 | 
| 2015 | 0 | 22 | 22 | 
| 2016 | 0 | 25 | 25 | 
| 2017 | 0 | 17 | 17 | 
| 2018 | 0 | 27 | 27 | 
| 2019 | 0 | 17 | 17 | 
| 2020 | 0 | 12 | 12 | 
| 2021 | 0 | 17 | 17 | 
| 2022 | 0 | 1 | 1 | 
| 2023 | 0 | 1 | 1 | 
| 2024 | 1 | 2 | 3 | 
| 2025 | 0 | 3 | 3 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Mice, Nude" by people in Profiles.
						
					
								- 
								
Loss of DRD5P2 in hypoxia attenuates Rock2 degradation to promote EMT and gastric cancer metastasis. Biochim Biophys Acta Mol Basis Dis. 2025 Aug; 1871(6):167858.
															
								 
							
								- 
								
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance. J Vis Exp. 2025 Feb 14; (216).
															
								 
							
								- 
								
L3MBTL3 and STAT3 collaboratively upregulate SNAIL expression to promote metastasis in female breast cancer. Nat Commun. 2025 01 02; 16(1):231.
															
								 
							
								- 
								
Sonopermeation With Size-sorted Microbubbles Synergistically Increases Survival and Enhances Tumor Apoptosis With L-DOX by Increasing Vascular Permeability and Perfusion in Neuroblastoma Xenografts. Ultrasound Med Biol. 2025 02; 51(2):348-357.
															
								 
							
								- 
								
Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter. Carcinogenesis. 2024 Sep 11; 45(9):696-707.
															
								 
							
								- 
								
IGF2BP3 promotes mRNA degradation through internal m7G modification. Nat Commun. 2024 Aug 28; 15(1):7421.
															
								 
							
								- 
								
Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft model. Int J Hyperthermia. 2023; 40(1):2222941.
															
								 
							
								- 
								
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers. J Clin Invest. 2022 02 15; 132(4).
															
								 
							
								- 
								
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. Nat Commun. 2021 11 09; 12(1):6468.
															
								 
							
								- 
								
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021 11 02; 37(5):109957.